VITAS Expects a Steady 2024 for Revenue, Growth
12/06/23 at 04:00 AM
VITAS Expects a Steady 2024 for Revenue, Growth
Hospice News
December 4, 2023
After the tumultuous years of the pandemic, VITAS Healthcare expects a stable growth trajectory heading into 2024. Florida-based VITAS is a subsidiary of Chemed Corp. Though the company has not yet released financial guidance for 2024, VITAS anticipates a “predictable” 2024 in terms of earnings and growth, executives said at Monday’s Bank of America Healthcare Conference.